Home

Case Study

Publication of a Real-World Study Supports an Immunotherapy in a Highly Competitive Market

Publication of a Real-World Study Supports an Immunotherapy in a Highly Competitive Market

McKesson
Pages 1 Pages

Overview A leading biopharma company needed to build market share for an anti-PD-1 immunotherapy in a highly competitive immuno-oncology space. Utilizing observational analysis of patients identified by the iKnowMed ? oncology EHR, McKesson helped the biopharma company conduct a real-world study of the effectiveness of pembrolizumab, which was recently published in the Journal of Immunotherapy. At a Glance Need: A leading biopharma company

Join for free to read

Related Solution Sets

Healthcare Industry

You Might Also Like


Software + Tech Marketing In The Real World
Report Software + Tech Marketing In The Real World
Hubspot

Creating the Future of Clinical Research and Post-Approval Insight Using Real-World Data
Ebook Creating the Future of Clinical Research and Post-Approval…
Intersystems

Real-world data: The growth guide for biotech and pharma
White Paper Real-world data: The growth guide for biotech and pharma
Merative

Securing the Real World: Accelerating Collaboration, Minimizing Risk
White Paper Securing the Real World: Accelerating Collaboration, Minimizing…
Zoom

More from McKesson


Using Real-World Evidence to Accelerate Drug Approvals for Rare Diseases
Case Study Using Real-World Evidence to Accelerate Drug Approvals for Rare…
McKesson

Real-World Evidence: Leveraging Electronic Health Records to Improve Patient Outcomes
Case Study Real-World Evidence: Leveraging Electronic Health Records to…
McKesson

Case Study
Case Study Case Study
McKesson

Case Study
Case Study Case Study
McKesson
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info